(Q33811501)

29 July 2017

1 reference

title

Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis. A review of the literature (English)

1 reference

29 July 2017

Van Laborde S

1

1 reference

29 July 2017

Scher RK

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

37-46

1 reference

Mohs micrographic surgery for the treatment of in situ nail apparatus melanoma: a case report

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Hutchinson's sign: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Longitudinal melanonychia (melanonychia striata): diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Rational design of receptor-selective retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

A simplified protocol of steroid injection for psoriatic nail dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Once-weekly fluconazole in the treatment of onychomycosis: introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Itraconazole oral solution for the treatment of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Onychomycosis in children: prevalence and management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Factors that may affect the response of onychomycosis to oral antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Antifungal agents: an overview. Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Fluconazole for the treatment of onychomycosis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Onychomycosis in children: prevalence and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Systemic antifungal agents used to treat onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

1 reference

7 January 2021

Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Tazarotene in combination with topical corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Pharmacokinetics and safety review of tazarotene

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

New therapies for onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Bowen's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Psoriasis of the nail

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Treatment of onychomycosis with terbinafine in patients with Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

Topical anthralin therapy for refractory nail psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970145-5

1 reference

7 January 2021

10.1016/S0733-8635(05)70145-5

Identifiers

DOI

1 reference

29 July 2017

1 reference